Answers are grounded in this paper and cite their sources.
Shows defective autophagy increases septic acute kidney injury in aging kidneys, suggesting therapeutic enhancement of autophagy.
Sepsis‐associated acute kidney injury (SA‐AKI) is a common and devastating disease that has a significantly higher incidence and greater severity in elderly patients, but the molecular basis underlying SA‐AKI in the elderly is largely unknown. Recent studies have proved autophagy as an intrinsic protective mechanism against AKI; however, the role and regulation of autophagy in aging kidneys remain unclear. Here we demonstrate that defective autophagy activation in aging kidneys is a key to their susceptibility to SA‐AKI. In our experiments, the ability of autophagy activation was impaired in aging kidneys in response to SA‐AKI in mice. In vitro, activation of autophagy with TAT‐Beclin‐1 peptide mitigated lipopolysaccharide (LPS)‐induced apoptosis and inflammation in senescent renal proximal tubular cells. Single‐cell sequencing revealed significant age‐related alterations in autophagy‐associated genes in septic AKI, including TFEB. Overexpression of TFEB could partially restore autophagic activity in senescent renal tubular cells and protect them from LPS‐induced damage. Moreover, in vivo treatment with the curcumin analog C1 (a TFEB activator) enhanced autophagic function in aging kidneys and reduced LPS‐induced AKI. These results demonstrate the defective autophagy activation in aging kidneys, which contributes to the SA‐AKI sensitivity and susceptibility in the elderly, suggesting a therapeutic strategy by enhancing autophagy.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: